The work behind the name.
Integra LifeSciences supplies medical technologies across specialty surgery and tissue reconstruction. It acquired Acclarent in April 2024, adding sinus balloon dilation, Eustachian tube dilation and surgical navigation to its ENT business. This profile follows the current parent company rather than presenting Acclarent as an independent company, with attention to portfolio changes and commercial execution.
WHY FOLLOW
Its acquisition of Acclarent places sinus and Eustachian tube technologies within a broader surgical company.
